CIDR utilizes Isilon scale-out NAS for genotyping and statistical genetics services

Isilon® Systems (Nasdaq: ISLN) today announced that the Center for Inherited Disease Research (CIDR) at Johns Hopkins University is using Isilon scale-out NAS to power its leading-edge genotyping and statistical genetics services, which generate up to three terabytes of new data per day. By deploying Isilon IQ, CIDR has unified its entire genotyping workflow onto a single, high performance, highly scalable, shared pool of storage, accelerating data access and processing speeds to increase research productivity, while reducing storage management costs.

Using Isilon scale-out NAS, with its OneFS® operating system software, CIDR has unified its vast repositories of genetic information into a single, easy-to-use, efficient storage infrastructure that scales both capacity and performance in lock-step, eliminating the cost and complexity barriers of traditional storage architectures. With Isilon IQ, CIDR's genomic data is immediately and reliably accessible across workstations, locations and protocols, enabling CIDR's researchers to store and analyze information more quickly and with greater accuracy.

"Whether identifying the genetic markers for lung cancer or the precursors for type 2 diabetes, genotyping has already made a significant impact in modern medicine," said Sam Grocott, senior director of product management, Isilon Systems. "CIDR is leading by example with its integration of next-generation scale-out NAS and leading-edge genetic analysis to drive continued innovation and discovery in fighting life-threatening diseases."

Source:

Isilon Systems

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CRISPR technology reveals essential noncoding RNAs in the human genome